Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.95% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.98% |
| 4 | Financials | 6.14% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Invesco Leisure and Entertainment ETF
PEJ
$360M
| $3.15M | ﹤0.01% |
77,427
+6,870
| +10% | +$276K |
|
2952
Viemed Healthcare
VMD
$336M
| $3.15M | ﹤0.01% |
326,108
+125,453
| +63% | +$1.09M |
|
2953
Star Holdings Shares of Beneficial Interest
STHO
$119M
| $3.15M | ﹤0.01% |
+181,082
| New | +$3.52M |
|
2954
Schrodinger
SDGR
$1.47B
| $3.15M | ﹤0.01% |
+119,551
| New | +$2.84M |
|
|
ACH
2955
Accendra Health
ACH
$93.1M
| $3.15M | ﹤0.01% |
216,297
-180,190
| -45% | -$3.23M |
|
|
BECN
2956
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.14M | ﹤0.01% |
53,400
-204,909
| -79% | -$12M |
|
2957
Ingevity
NGVT
$2.39B
| $3.14M | ﹤0.01% |
43,874
-83,190
| -65% | -$6.6M |
|
2958
CALL
Relay Therapeutics
RLAY
$4.11B
| $3.13M | ﹤0.01% |
190,000
+135,800
| +251% | +$2.44M |
|
|
YMAB
2959
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.12M | ﹤0.01% |
623,091
-505,611
| -45% | -$2.06M |
|
2960
PUT
Etsy
ETSY
$7.67B
| $3.12M | ﹤0.01% |
28,000
-316,800
| -92% | -$39.3M |
|
2961
PennyMac Financial
PFSI
$3.81B
| $3.12M | ﹤0.01% |
52,297
-54,884
| -51% | -$3.4M |
|
2962
iShares S&P 500 Growth ETF
IVW
$76.8B
| $3.11M | ﹤0.01% |
+48,692
| New | +$2.98M |
|
2963
SFL Corp
SFL
$1.72B
| $3.11M | ﹤0.01% |
327,458
-19,078
| -6% | -$188K |
|
2964
PUT
Sarepta Therapeutics
SRPT
$2.2B
| $3.1M | ﹤0.01% |
+22,500
| New | +$2.92M |
|
2965
CALL
Airbnb
ABNB
$112B
| $3.1M | ﹤0.01% |
24,900
-4,400
| -15% | -$502K |
|
2966
Ligand Pharmaceuticals
LGND
$5.59B
| $3.09M | ﹤0.01% |
41,996
-167,611
| -80% | -$11.9M |
|
2967
Vericel Corp
VCEL
$2.1B
| $3.08M | ﹤0.01% |
105,055
-268,041
| -72% | -$7.77M |
|
2968
Entravision Communication
EVC
$745M
| $3.07M | ﹤0.01% |
508,021
+290,924
| +134% | +$1.8M |
|
2969
The Greenbrier Companies
GBX
$1.42B
| $3.07M | ﹤0.01% |
95,544
+85,503
| +852% | +$2.58M |
|
2970
CALL
TG Therapeutics
TGTX
$8.26B
| $3.07M | ﹤0.01% |
204,400
-46,900
| -19% | -$712K |
|
2971
Minerals Technologies
MTX
$2.24B
| $3.07M | ﹤0.01% |
50,849
+31,223
| +159% | +$1.94M |
|
2972
Flowers Foods
FLO
$1.51B
| $3.07M | ﹤0.01% |
112,050
-2,651,817
| -96% | -$73.1M |
|
|
ISRL
2973
DELISTED
Israel Acquisitions Corp
ISRL
| $3.07M | ﹤0.01% |
+300,000
| New | +$3.06M |
|
2974
Credit Acceptance
CACC
$6.18B
| $3.07M | ﹤0.01% |
7,036
-12,225
| -63% | -$5.37M |
|
2975
Independent Bank Corp
IBCP
$818M
| $3.07M | ﹤0.01% |
172,623
-66,965
| -28% | -$1.45M |
|
Similar funds
Israel Englander's Q1 2023 Portfolio in Review
As of Q1 2023, Israel Englander held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Israel Englander withdrew a net $7.42B in Q1 2023, closing 1,206 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Israel Englander opened a new position in Warner Bros worth $96.9M.
- Israel Englander's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Israel Englander added most to Linde in Q1 2023, an estimated $374M increase.
- Israel Englander's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Israel Englander fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Israel Englander's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Israel Englander opened 987 new positions and closed 1,206 in Q1 2023.
- Israel Englander's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.